CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
62.29
3.73%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.16
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 60.05
Open 60.58
1-Year Change -33.92%
Day's Range 60.58 - 63.58
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 25, 2024 59.65 -3.56 -5.63% 63.21 67.70 58.77
Jul 24, 2024 86.86 0.42 0.49% 86.44 87.51 85.99
Jul 23, 2024 86.95 -0.20 -0.23% 87.15 88.18 86.62
Jul 22, 2024 87.91 1.46 1.69% 86.45 88.39 86.45
Jul 19, 2024 86.43 0.31 0.36% 86.12 87.38 85.68
Jul 18, 2024 85.76 -0.84 -0.97% 86.60 88.39 84.80
Jul 17, 2024 87.02 -0.36 -0.41% 87.38 88.27 86.58
Jul 16, 2024 87.65 -1.39 -1.56% 89.04 89.48 86.05
Jul 15, 2024 89.39 -1.50 -1.65% 90.89 91.20 88.84
Jul 12, 2024 90.88 -1.34 -1.45% 92.22 92.72 90.69
Jul 11, 2024 92.77 -1.14 -1.21% 93.91 95.18 92.74
Jul 10, 2024 93.70 0.70 0.75% 93.00 94.03 92.00
Jul 9, 2024 93.41 1.46 1.59% 91.95 93.59 91.24
Jul 8, 2024 91.79 0.26 0.28% 91.53 92.41 91.38
Jul 5, 2024 92.26 1.38 1.52% 90.88 92.38 90.35
Jul 3, 2024 91.02 0.46 0.51% 90.56 91.98 90.29
Jul 2, 2024 91.17 1.89 2.12% 89.28 91.29 89.24
Jul 1, 2024 90.16 -0.29 -0.32% 90.45 92.88 89.85
Jun 28, 2024 92.00 -1.43 -1.53% 93.43 93.84 91.94
Jun 27, 2024 93.27 1.61 1.76% 91.66 93.56 91.66

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Edwards Lifesciences Company profile

About Edwards Lifesciences Corp

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Edwards Lifesciences Corp revenues increased 19% to $5.23B. Net income increased 83% to $1.5B. Revenues reflect Transcatheter Aortic Valve Replacement segment increase of 20% to $3.42B, Surgical Heart Valve Therapy segment increase of 17% to $889.1M, Critical Care segment increase of 15% to $834.9M, United States segment increase of 18% to $2.96B, Europe segment increase of 26% to $1.19B.

Equity composition

Common Stock $1 Par, 12/10, 350M auth., 117,100,000 issd. less 2,000 shs. in Treas. @ $102M. Insiders control 0.64%. 4/3/00,Company spun off from Baxter International. 05/10, 2-for-1 stock split. 12/15, 2-for-1 stock split.

Industry: Advanced Medical Equipment & Technology (NEC)

One Edwards Way
IRVINE
CALIFORNIA 92614
US

People also watch

XRP/USD

0.61 Price
+1.640% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

67,928.50 Price
+3.990% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

19,029.00 Price
+1.080% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 7.0

ETH/USD

3,281.07 Price
+4.040% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading